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The Carcinoembryonic Antigen Gene Family: 
Structure, Expression and Evolution 
John Thompson, Wolfgang Zimmermann 
Institute o f Immunobiology, Universi ty o f Freiburg, F R G 
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Abstract. The molecular cloning of carcinoembryonic antigen (CEA) and several cross-
reacting antigens reveals a basic domain structure for the whole family, which shows struc-
tural similarities to the immunoglobulin superfamily. The CEA family consists of approxi-
mately 10 genes which are localized in two clusters on chromosome 19. So far, mRNA 
species for five o f these genes have been identified which show tissue variability in their 
transcriptional activity. Expression of some of these genes in heterologous systems has been 
achieved, allowing the localization of some epitopes. The characterization of a CEA gene 
family in the rat and a comparison with its human counterpart has been utilized in the 
development o f an evolutionary model. 
Introduction 
Carcinoembryonic antigen (CEA), whose 
expression appears to be oncodevelopmen-
tally regulated, is one of the most widely 
used human tumour markers. I t was origi-
nally discovered by Gold and Freedman [1] 
in colonic tumours and fetal gut and was 
apparently absent from the normal intestine. 
However, later studies also revealed the 
presence of CEA in normal tissues [2-5] . 
Despite the lack o f tumour specificity, the 
CEA concentration in sera is an important 
parameter in the post-operative surveillance 
of cancer patients [6, 7]. The presence of 
CEA on the surface of tumour cells has been 
exploited for the immunolocalization of pri-
mary tumours and their metastases using ra-
diolabeled antibodies [8]. First results have 
also been presented in an animal system as 
well as in cell culture, for the potential use of 
such antibodies linked with cytotoxic sub-
stances for therapeutic purposes [9, 10]. A 
number of review articles summarize the 
clinical uti l i ty of CEA and the reader is 
referred to more recent articles for detailed 
information [11, 12]. 
CEA is a highly glycosylated molecule 
with a molecular weight of 180,000. Glyco-
sylation inhibition studies show the protein 
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moiety to consist of a single polypeptide 
chain with an apparent molecular weight of 
approximately 80,000 [13]. Immunobio-
chemical studies have revealed a number o f 
closely related molecules, suggesting the ex-
istence of a gene family (table I) . However, 
the exact size of this family has been very 
difficult to ascertain for the following rea-
sons: 
(1) Various laboratories have described 
molecules which cross-react with CEA, and 
each molecule has received a different name. 
In some cases, these molecules could be 
identical; e.g., the classical NCA [31] is pre-
sumed to be identical with NGP [35], CEX 
[19], CCEA-2 [20] and CCA I I I [21]. 
(2) The molecular weights for what have 
been described as the same molecules vary in 
the literature; e.g., for NCA, values ranging 
from 40,000 to 120,000 can be found [29, 
31, 33, 35,41]. 
(3) The faecal antigens may or may not 
represent degradation products of CEA or 
other cross-reacting antigens, as already dis-
cussed [32]. 
(4) Variations in the molecular weight o f 
the same molecule could exist, depending on 
the degree of glycosylation. Such variations 
have been found for CEA-180 extracted 
from different tumours (160,000-240,000) 
[42, 43]. Similarly, NCA-50 ( M W 50,000) 
and TEX ( M W 85,000), which have been 
shown to have the same protein backbone, 
apparently differ only in their carbohydrate 
moieties [44]. 
(5) Investigators using polyclonal antisera 
may earlier have falsely described contami-
nants in their CEA preparations as being 
cross-reactive; e.g., al-anti-chymotrypsin, 
which is often co-purified with CEA [45]. 
Wi th the advent of monoclonal anti-
bodies (MAbs), an attempt has been made 
toward a more reliable definition of the var-
ious members of the CEA family. An ex-
change of monoclonal antibodies between a 
number of laboratories has been arranged 
under the auspices of the International Soci-
ety for Oncodevelopmental Biology and 
Medicine, and each participating group 
agreed to test all the MAbs with one stan-
dard preparation for each of the various 
CEA-related molecules. Although the results 
of these tests remain outstanding, and 
much useful information regarding the 
specificity of the different MAbs should be 
forthcoming, a completely reliable defini-
tion of the different family members still 
cannot be expected. Only an exact descrip-
tion of the basic structure for each molecu-
lar species can lead to a precise definition 
of this family. 
The existence of an antigen family is one 
of the reasons which have complicated the 
clinical application of CEA. As table I shows, 
CEA and many of the cross-reacting antigens 
occur in malignant and normal tissues. The 
classical NCA, for instance, is found in gran-
ulocytes and macrophages [30, 46-49], 
whereas BGP-1 is present in the epithelium 
of bile canaliculi [15]. This can lead to prob-
lems in the immunolocalization and immu-
notherapy of CEA-producing tumours, un-
less highly specific antibodies are employed 
[50]. A more exact description of the various 
members of this family, including an identi-
fication of the different epitopes, should help 
to improve the reliability of CEA as a tu-
mour marker. 
The existence of a gene family was al-
ready suggested through immunological 
studies, because most of the epitopes, includ-
ing those present on more than one family 
member, are located on the protein moiety 
of these molecules [51]. Protein sequence 
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Table I . The C E A family 
Antigen MW C H O Source Reference 
ßE-Pro t e in ? colon tumour 14 
Bi l ia ry glycoprotein I (BGP-I) 9 0 K 40 bile 15 
Bi l ia ry glycoprotein I I (BGP-I I ) 9 infected bile 15 
Bi l ia ry glycoprotein I I I (BGP- I I I ) ? infected bile 15 
Breast carcinoma glycoprotein (BCGP) 9 breast tumour 16 
Carcinoembryonic antigen 200 (CEA-200) 200K colon tumour 17 
Carcinoembryonic antigen 180 (CEA-180) 180K 60 colon tumour 1 
Carcinoembryonic antigen 160 (CEA-160) 160K colon tumour 18 
CEA-associated protein ( C E X ) ? colon/plasma 19 
Colonic carcinoembryonic antigen 2 (CCEA-2) ? colon/plasma 20 
Colonic carcinoma antigen I I I ( C C A - I I I ) 6 0 K serum 21 
Fetal sulphoglycoprotein antigen (FSA) ? stomach 22 
Gastric CEA-l ike antigen (Celia) ? stomach juices 23 
M e c o n i u m antigen ( M A ) 185K meconium 24 
M e c o n i u m antigen-100 (MA-100) 105K 50 meconium 25 
Melanoma/carcinoma cross-reacting oncofetal Ag 95 -150K melanoma/carcinoma 26 
Non-specific cross-reacting antigen 2 (NCA-2) 160K 50 meconium 27 
Non-specific cross-reacting antigen 160 (NCA-160) 160K granulocytes 28 
Non-specific cross-reacting antigen 110 (NCA-110) 110K spleen 29 
Non-specific cross-reacting antigen 97 (NCA-97) 97K colon tumour 18 
Non-specific cross-reacting antigen 95 (NCA-95) 95K granulocytes 30 
Non-specific cross-reacting antigen 90 (NCA-90) 9 0 K granulocytes 28 
Non-specific cross-reacting antigen 75 (NCA-75) 7 5 K colon tumour 18 
Non-specific cross-reacting antigen 50 (NCA-50) 50K 30 granulocytes 31 
N o r m a l colon washings antigen ( N C W ) ? colon 5 
N o r m a l faecal antigen 1 (NFA-1) 2 0 - 3 0 K 13 faeces 32 
N o r m a l faecal antigen 2 (NFA-2) 170K faeces 33 
N o r m a l faecal cross-reacting antigen ( N F C A ) 8 0 - 9 0 K faeces 34 
N o r m a l glycoprotein (NGP) 6 0 K lung 35 
Tumour-extracted antigen ( T E X ) 85K 60 colon tumour 36 
165K antigen 165K meconium 25 
160K antigen 160K colon tumour 37 
128K antigen 128K 50 colon tumour 38 
9 0 K antigen 9 0 K colon tumour 39 
50K antigen 50K 25 colon tumour 40 
4 0 K antigen 4 0 K colon tumour 37 
The antigens are listed alphabetically, or where no name exists, according to their molecular weights. 
C H O = Carbohydrate moiety expressed as a percentage o f the total molecular weight ( M W ) . 
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data has already revealed close homology 
but also distinctive differences between CEA 
and NCA [29, 36]. However, the determina-
tion of the complete primary amino-acid 
structure has proven difficult due to the large 
size and high degree of glycosylation of CEA 
and related molecules (table I ) . Such infor-
mation can be more easily provided at the 
D N A level. Determination of the primary 
structures of the various molecules be-
longing to the CEA family should give a bet-
ter idea of their number as well as their struc-
tural interrelationships. 
Through cloning the genes for CEA and 
its cross-reacting antigens a number of prob-
lems concerning the reactivity pattern o f 
CEA can be dismissed. For example, studies 
on engineered mutants for each gene should 
help to characterize the different epitopes, 
and molecule-specific determinants may be 
resolved. Comparative expression studies o f 
the various genes in different tumours and 
their corresponding normal tissues could re-
veal the possibility that other members of 
the CEA family may also be useful as tumour 
markers. From a biological point of view, i t 
may be possible to gain information as re-
gards the function and evolution of the CEA 
family. Also, studies on a tissue-specific or 
oncodevelopmentally regulated expression 
of the different CEA family members should 
lead to much useful information with respect 
to the regulation of gene expression in gener-
al. These various aspects wi l l be discussed in 
more detail below. 
The purpose of this review is to summa-
rize the results gained so far through studies 
at the D N A / R N A level. We shall not, how-
ever, review all that is known about the 
immunochemistry of CEA and related mole-
cules, as this has been well documented else-
where [12, 52]. 
History of C E A Cloning 
Despite the existence of monospecific, 
polyclonal CEA antisera and CEA-specific 
MAbs as well as knowledge of the first 26 
amino-acids from the N-termini of both 
CEA and NCA [29, 36], attempts to clone 
CEA and related genes were unsuccessful for 
a long time. The first results on the charac-
terization of CEA mRNA were gained 
through in vitro translation of total poly(A)-
mRNA from a rectal carcinoma, followed by 
immunoprecipitation with antibodies to 
CEA [53]. A polypeptide (approximate M W 
80,000) was identified as a non-glycosylated 
CEA precursor, with a relative abundance of 
0.6% of total translated protein. This protein 
was apparently resistant to CNBr cleavage, a 
result in agreement with the lack of methio-
nine in colonic CEA. The size of the CEA 
mRNA was estimated to be 3,100 nucleo-
tides by agarose gel electrophoresis [54]. 
However, before cDNA or genomic clones 
could be isolated, additional protein sequence 
data was necessary. A major limitation in 
gaining this data, as mentioned, has been the 
high level of glycosylation for different mem-
bers of the CEA family [12] (table I). This 
problem was eventually resolved [55] and the 
newly gained protein sequences paved the 
way for the molecular cloning and an un-
equivocal identification of different members 
of the CEA family. Thus, the isolation and 
characterization of CEA cDNA clones has 
recently been achieved in different laborato-
ries at approximately the same time. Basical-
ly, two approaches were successful: 
(1) Screening of a cDNA library derived 
from colonic tumours or from a colonic tu-
mour cell line poly(A)-mRNA, using syn-
thetic oligonucleotides based on known pro-
tein sequence data [56, 57]; 
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Fig. 1. Domain structure o f CEA (a) and NCA-50 
(b), based on deduced amino-acid sequences. Four 
major domains are indicated by differential shading 
and letters above the blocks: a leader peptide (L) , a 
N-terminal domain (N) , a repeating uni t (R), o f which 
three copies are present in CEA (a: R I - R I I I ) , but only 
one i n NCA-50 (b), and a hydrophobic, carboxyl-ter-
mina l region (C). The repeat regions can be further 
d iv ided into two subdomains, R A and R B . A m i n o -
acid numbers are presented below the blocks. The 
positions o f cysteine residues are indicated in the 
blocks (C). 
(2) screening of cDNA libraries derived 
from colonic tumours and normal colon 
poly(A)-mRNA as well as from a colonic 
tumour cell line (LoVo) in expression vec-
tors with CEA antisera [58, 59]. 
Parallel to this, an NCA-50 gene was iso-
lated from a human genomic library through 
screening with synthetic oligonucleotides 
[60, 61 ] . A second gene belonging to the CEA 
family was isolated after transfection of ge-
nomic D N A from a CEA-producing cell line 
(LoVo). In order to achieve this, primary 
and secondary mouse L-cell transfectants ex-
pressing a CEA-like molecule were selected 
by fluorescence-activated cell sorting, and 
the transfected D N A was identified through 
hybridization to a CEA-like cDNA clone 
[59]. 
Primary Structure of C E A and Its mRNA 
The primary structure of CEA has been 
reported independently from four laborato-
ries [56-58, 62]. The authenticity of these 
clones has been proven through a compari-
son with protein sequence data for CEA [55, 
63, 64]. However, i t has still not been deter-
mined unequivocally whether the gene cor-
responding to these cDNAs codes for all 
CEAs (table I) or individual CEA species. 
The amino-acid sequences, as deduced from 
the nucleotide sequences of the cDNAs, 
show that CEA is synthesized as a precursor 
of 702 amino-acids. The leader peptide (34 
amino-acids) is followed by the mature CEA 
peptide (668 amino-acids). The molecular 
weight for the protein moiety of the mature 
CEA molecule (minus leader) can be calcu-
lated to be 72,893. Due to the presence of 
three internal repeats, this peptide can be 
divided into a number of structural do-
mains, which are shown in figure la. 
The three repeat domains of 178 amino-
acids each reveal an exceptionally high de-
gree of sequence similarity, having between 
67 and 73% of their amino-acids in common 
(table I I ) , and each contains four cysteine 
residues at precisely the same positions. I f 
conservative exchanges are allowed, then the 
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degree of similarity is even higher. The de-
gree of conservation at the nucleotide level is 
also very high (80-83% similarity). Other 
proteins with internal repeats have been re-
ported in the literature, but the internal de-
gree of similarity of the repeating domains in 
CEA is the highest reported so far [56]. I t is 
also noticeable that the CEA repeats are rel-
atively long [65]. As shown in figure 1, they 
can be further divided into two subdomains 
( R A and RB) of approximately equal size 
which reveal sequence similarity to each 
other as well as to the N-terminal domain 
(approximately 20% at the amino-acid level) 
[66]. The importance of this wi l l be dis-
cussed in more detail below. 
Another region of interest is the C-termi-
nal domain which consists of 26 amino-acids 
and is strongly hydrophobic. This provides a 
potential insertion region for CEA into the 
plasma membrane and has just the right 
length to span the l ipid bilayer [67]. Surface 
labelling experiments with intact cells indi-
cate that the rest of the molecule projects 
outward from the cell [ R . Bhardwaj: per-
sonal commun.]. However, this sequence 
may be the signal for attachment of a glyco-
phospholipid tail after cleavage of the hydro-
phobic domain by analogy with LFA-3 [68], 
Thy-1 and presumably N - C A M [69]. The 
lack of hydrophilic amino-acids at the car-
boxyl terminus, which normally anchor 
membrane proteins, would support this 
mode of attachment. Determination o f the 
presence or absence of this region in the 
mature protein should clarify this specula-
tion. 
Twenty-eight potential N-glycosylation 
sites (fig. 3) are found i n the CEA peptide 
[57, 58], many of which have been identified 
as being glycosylated through protein analy-
ses [55]. This value is considerably lower 
Table I I . Sequence similari ty between correspond-
ing domains o f CEA and NCA-50 
Domains Degree of sequence similarity 
compared 
nucleotide amino-acid 
level. % level, % 
L C E A / L N C A 83 74 
N - t e r m i n u s c E \ / 
N - terminusNCA 93 89 
R I C E A / R N C A 90 84 
R I I C E A / R N C A 86 76 
R I U C E A / R N C A 83 73 
R I C W R I I C E A 83 73 
R I C E A / R I U C E A 82 72 
R I I C E A / R H I C E A 80 67 
C - t erminuscEA/ 
C - terminusNCA 85 a 7 1
a 
a The C-terminal domain o f NCA-50 is two amino-
acids (or six nucleotides) shorter than the correspond-
ing domain i n CEA. Therefore, the calculations are 
based only on the corresponding 24 amino-acids and 
their codons. 
than the values of 70 [12] or 40 sites [70] 
predicted from chemical analyses. In order 
to achieve a molecular weight of 180,000 
and assuming that all 28 potential sites are 
glycosylated, the carbohydrate chain length 
would have to average 20 residues. The pos-
sible existence of O-glycosylation sites as dis-
cussed by Shively and Beatty [12] should 
only lead to marginal changes in these val-
ues. 
One of the criteria which has been uti-
lized to distinguish CEA from NCA is the 
apparent lack of methionine in CEA [71]. 
However, as has been shown from the 
cDNA-derived primary structure, one me-
thionine does exist in the C-terminal domain 
of CEA [56, 58]. As this amino-acid is lo-
cated only 11 amino-acids from the carboxyl 
terminus, the larger peptide resulting from 
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Fig. 2. Domain model for CEA and 
NCA-50 reveals a close resemblance to 
the immunoglobul in superfamily. The 
domains for CEA and NCA-50 are des-
ignated as in figure 1. Variable (V) and 
constant domains (C) are indicated for 
the immunoglobul in superfamily. The 
dotted lines represent disulphide 
bridges. Th is figure has been modif ied 
after Hunkapil ler and Hood [100], 
where the individual members o f the 
immunoglobul in superfamily are de-
scribed i n more detail. 
GlyCOproU 
the standard CNBr treatment would not be 
noticeably smaller in SDS-PAGE analyses 
than the native CEA molecule. The small 
peptide would not be visualized as this wi l l 
migrate out of the gel. For this reason i t is 
understandable that earlier investigations 
could not detect the presence of methionine 
in CEA [72]. On the other hand, as already 
discussed, this methionine-containing C-ter-
minal region may be absent from the mature 
molecule, i f CEA is attached to the mem-
brane by a glycophospholipid tail. In this 
case, the mature CEA molecule would con-
tain no methionine. 
A domain model has been proposed [57, 
60, 66], which assumes that neighbouring 
cysteine residues form disulphide bonds. A 
model for CEA is shown in figure 2. I t is 
obvious that such a secondary structure 
shows a strong similarity to members of the 
immunoglobulin superfamily [73]. The rele-
vance of this wi l l be discussed in more detail 
below. 
Analysis of the CEA cDNA also revealed 
a region of interest in the non-coding region 
of the mRNA. The 3'-untranslated region of 
the processed CEA mRNA contains a trun-
cated, Alu-type, repetitive sequence flanked 
by a pair of direct repeats. Human Alu D N A 
is a head-to-tail dimer of two similar se-
quences with a length of approximately 130 
bp. Both monomers can be distinguished by 
the presence of a 31-bp insert in the second 
(right) repeat [74]. In the CEA mRNA, ap-
proximately 70 nucleotides are deleted from 
the 5'-terminal region of the first (left) half of 
the dimer [56, 58]. The significance of the 
presence of this truncated Alu sequence is 
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unknown. The 5'-untranslated region has a 
length of 102 nucleotides as determined by 
primer extension experiments [57]. 
Primary Structure of NCA-50 and Its 
mRNA 
The primary structure of NCA-50 has re-
cently been determined [75, 101]. The au-
thenticity of the NCA-50 cDNA clones was 
proven through a comparison with protein 
sequence data which were recently exten-
sively investigated [55, 76]. NCA-50 is syn-
thesized as a precursor of 344 amino-acids. 
The leader peptide (34 amino-acids) is fol-
lowed by the mature NCA-50 peptide (310 
amino-acids). A molecular weight for the 
protein moiety of the mature NCA-50 (mi-
nus leader) can be calculated to be 33,456. In 
contrast to CEA, NCA-50 does not contain 
an internal repeating structure. However, 
due to its strong sequence similarity to CEA, 
NCA-50 can also be structurally subdivided 
into a number of domains, which are pre-
sented in figure lb . 
I t is obvious that the major difference 
between NCA-50 and CEA is that the former 
contains only one 'repeat' domain which ac-
counts for the large difference in size be-
tween the two polypeptides. This is the ma-
jor distinction between the two proteins; 
otherwise, an extremely high conservation 
between the corresponding domains is ap-
parent at both the amino-acid as well as at 
the nucleotide levels. These values are pre-
sented in table I I and wil l also be discussed 
in more detail below. 
NCA-50 contains 11 potential N-glycosy-
lation sites [75] (fig. 3). Amino-acid se-
quence analyses have revealed that some of 
these sites are always glycosylated whereas 
others are only occasionally or never glycosy-
lated [76]. It has recently been shown that 
TEX ( M W 85,000, see table I) and NCA-50 
( M W 50,000), after deglycosylation, yield a 
polypeptide of the same size [44]. Protein 
sequence data for both molecules indicate 
identity, which suggests that the size differ-
ence is, in this case, due to variable glycosy-
lation of just one polypeptide. 
A few other interesting features about 
NCA-50 should be mentioned. First o f all, in 
contrast to CEA, NCA-50 contains three me-
thionine residues, which correlates with ear-
lier observations [29]. Secondly, NCA-50 
also contains the hydrophobic C-terminal 
domain, which, although being slightly 
shorter than the corresponding region in 
CEA, also provides a potential membrane 
insertion region. This suggests that NCA-50, 
like CEA, is membrane-bound (fig. 2). 
Thirdly, the regions of variability between 
CEA and NCA-50 at the amino-acid level 
are often clustered, suggesting the existence 
of potential molecule-specific epitopes 
(fig. 3). This important finding could possi-
bly be utilized in future in the production of 
molecule-specific antibodies which would be 
of great clinical significance. 
Figure 2 shows a domain model for NCA-
50, which has obvious similarities to CEA 
and to molecules belonging to the immuno-
globulin superfamily. 
Analysis of the cDNA has revealed that 
the 3'-untranslated region o f NCA-50 
mRNA diverges completely from the corre-
sponding region in the CEA mRNA [75]. 
Apart from the first 40 nucleotides directly 
downstream from the carboxyl terminus, no 
homology can be found beyond this point. 
Further, the NCA-50 mRNA does not con-
tain any Alu-like repetitive sequences. As 
wil l be described below, these differences 
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Fig. 3. Amino-acid sequence comparison between CEA and NCA-50. Corresponding domains are grouped 
together. I n each case, dots indicate identity to the amino-acids o f the CEA domains shown in the top line o f 
each group. Dashes indicate amino-acid deletions in comparison wi th CEA. Potential N-glycosylation positions 
are underlined. 
have been utilized in the identification of the 
CEA and NCA-50 mRNAs in RNA blot hy-
bridization experiments. The NCA-50 3'-
untranslated region is similar to correspond-
ing regions in other members of the CEA 
family, whereas the 3'-non-coding region 
from the CEA mRNA is apparently unique 
to two genes, maximally [77]. Assuming a 
common origin for the CEA-gene family, one 
may speculate that a new exon could have 
been inserted into the NCA-50-like, 3'-un-
translated region of a primordial CEA gene. 
A similar event has been suggested to explain 
the abrupt divergence in the 3'-untranslated 
region of preprocathepsin B mRNA in the 
rat and mouse [78]. The major differences 
between the CEA and NCA-50 mRNAs in 
this region may also have some functional 
importance. I t has been discussed elsewhere 
that mRNA 3'-untranslated regions may 
have regulatory functions [79]. I t wi l l be of 
interest in the future to test for such possible 
functions in the regulation of expression of 
CEA and NCA-50 genes. 
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Relationship to the Immunoglobulin 
Superfamily 
As already indicated in figure 2, the pro-
posed secondary structures for CEA and 
NCA-50 reveal a strong similarity to mem-
bers of the immunoglobulin superfamily. 
This structure is based on the supposition 
that neighbouring cysteine rests form disul-
phide bridges, although this still remains to 
be experimentally verified. However, a com-
parison of deduced amino-acids has shown 
conservation of critical amino-acids in com-
parison with other immunoglobulin super-
family members, indicating that the CEA 
gene family may be placed within this super-
family [55, 57, 66]. As has already been men-
tioned, the half repeats ( R A and R B ) as well 
as the N-terminal domains of CEA and 
NCA-50 (fig. 1) show sequence similarity to 
each other. Closer computer analyses of the 
deduced secondary structure of these regions 
indicate an anti-parallel arrangement of beta 
strands in two beta sheets, which is indeed 
the typical feature of the basic immunoglob-
ulin fold [73]. So far, conservation of the d i -
sulphide bond has been adopted as being 
invariant for the immunoglobulin super-
family. Indeed, this characteristic may be 
applicable to the half repeat domains of CEA 
and NCA-50. However, the N-terminal do-
mains lack cysteine residues, but their com-
puter-deduced secondary structures indicate 
that they, too, can form the typical immuno-
globulin fold. This has been discussed in a 
recent review by Williams [73], who suggests 
that the conserved disulphide bond should 
no longer be the last invariant characteristic 
of these immunoglobulin-related domains. 
Accordingly, the N-terminal regions of CEA 
and NCA-50 should, therefore, also be classi-
fied as immunoglobulin-like domains. This 
means that CEA is composed of seven such 
domains, and NCA-50 of three. These do-
mains form the basic backbone of these two 
antigens, and as wil l be discussed below, pre-
sumably for the whole CEA family. 
Evidence has been presented that CEA 
may exist in the cell as a non-covalently 
bound dimer, composed of identical or 
closely similar monomers [80]. Similar inter-
molecular interactions have been suggested 
for NCA [81]. Such structures are known to 
exist for other members o f the immunoglob-
ulin superfamily (fig. 2). However, before 
conclusive evidence is available, CEA and 
NCA-50 are depicted as monomers in fig-
ure 2. 
I t is of great interest to note that many of 
the other members o f the immunoglobulin 
superfamily are often, but not invariably, 
membrane-bound (fig. 2). Furthermore, 
where known, all appear to have some kind 
of recognition or receptor function. The 
membrane localization, as well as the strong 
resemblance of CEA and NCA-50 to other 
immunoglobulin superfamily members is 
strongly indicative o f a similar function for 
these two gene products. Although no exper-
imental evidence is so far available, this is 
the first indication of a function for CEA and 
NCA-50, which may be used as a starting 
point for directed experiments along these 
lines. 
The CEA-Gene Family 
From the above-mentioned primary 
structures for CEA and NCA-50 a basic 
structure for the whole family may be pre-
dicted. In order to get a more exact idea of 
the size of this family, D N A fragments from 
different domains of the NCA-50 gene were 
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used to probe total human DNA, digested 
with different restriction endonucleases, in 
Southern blot hybridization analyses [58-
60]. The mean number o f fragments which 
hybridized with a given probe was taken as 
an indication of the number of gene loci. The 
results indicate the existence of approxi-
mately 9 separate genes. However, the exact 
size of the family can only be determined 
when the separate genes are isolated and 
characterized. Work is in progress in a num-
ber o f laboratories at both the cDNA as well 
as at the genomic level in this direction. In 
our laboratory, we have isolated six indepen-
dent clones from a human genomic library 
through differential hybridization with var-
ious probes. The results indicate that each 
clone represents a different member of the 
CEA family, and the basic domain structure 
seen for CEA and NCA-50 appears to be 
conserved. A model may be proposed which 
could in part explain the size variability of 
the CEA family, based on differences in the 
number of immunoglobulin-like domains, 
which is, indeed, applicable for CEA and 
NCA-50. 
However, recent results indicate that this 
model alone cannot explain the total vari-
ability of the CEA family. Additional do-
mains have also been found for at least one 
family member [62]. In this case, an addi-
tional cytoplasmic domain has been identi-
fied, the structure of which shows no homol-
ogy to any of the other domains described so 
far. Furthermore, the degree of glycosylation 
may also have profound effects on the mo-
lecular size. As discussed above, recent re-
sults indicate that T E X (table I) and the 
classical NCA-50 probably have the same 
protein backbone, and the variations in mo-
lecular weight are due to differential glycosy-
lation [44]. 
Genomic Organisation and Chromosomal 
Localization 
Analyses at the genomic level for mem-
bers of the CEA family indicate a strong cor-
relation between the exon structure and the 
domains [60, 61, 82]. The structure for 
NCA-50, as far as it is known, is as follows: 
The first exon apparently contains the 5'-
untranslated region and approximately two 
thirds of the leader sequence. The second 
exon contains the rest of the leader and the 
complete N-terminal domain. The third 
exon correlates exactly with the R A 'repeat' 
subdomain [82] (fig. lb) . Such half-repeats, 
corresponding to immunoglobulin-like do-
mains, appear to represent a basic building 
unit for the CEA gene family, as wi l l be dis-
cussed in more detail below. Unpublished 
data reveal a conservation of this exon/do-
main structure in other members of the CEA 
gene family. 
We have recently analysed three other 
genes belonging to the CEA family in and 
around the N-terminal exon, and a number 
of interesting results have been obtained [re-
sults to be published]. So far, these genes 
have been unequivocally identified as be-
longing to the CEA gene family through 
strong sequence similarities to CEA and 
NCA-50. However, distinctive differences 
reveal that they represent separate genes. At 
present they cannot be assigned to a particu-
lar protein, assuming that they are active 
genes. 
For this reason we propose a temporary 
nomenclature system for these as well as 
other genes, until their products have been 
identified. In other to avoid further confu-
sion with the existing nomenclature (table I) , 
we propose that each gene should be as-
signed numerically, according to the species. 
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In addition, their assignment to the CEA 
gene family should also be included. Thus, 
the following abbreviation is suggested 
for unidentified human CEA-like genes: 
hsCGM 1, hsCGM 2 etc. {Homo sapiens 
CEA gene-family member). As wi l l be dis-
cussed below, four CEA-like genes have been 
found in the rat (Rattus norvegicus), which 
we shall name r n C G M l - r n C G M 4 . 
A poly(dC-dA) sequence has been found 
in the first intron of the NCA-50 gene [60, 
61]. This potential regulatory region is lo-
cated approximately 100 nucleotides up-
stream from the start of the second exon, 
which contains part of the leader sequence 
and the complete N-terminal domain. 
Poly(dC-dA)-poly(dG-dT) sequences have 
been reported in a number of genes [83], and 
they are believed to form Z-DNA [84]. Such 
sequences could play a role in the regulation 
of gene expression [85, 86], or in gene rear-
rangement [87], as well as recombination 
[88, 89]. Although the intron sequences for 
three other genes are very similar in compar-
ison with NCA-50 in the region between the 
first and second exons, they vary with regard 
to this poly(dC-dA) sequence. In one gene 
(hsCGM 1), this sequence is very short [ (dC-
d A ) 3 ] , in a second gene (hsCGM 2), i t is of 
medium length [ (dC-dA) 8 ] , and in a third 
gene (hsCGm 3), it has the same length as in 
the NCA-50 gene [ (dC-dA) 1 8 ] . In addition, i t 
is followed by a poly(dG-dT) region of ap-
proximately equal length. In this latter case, a 
secondary structure could be formed, which 
may also have some regulatory function. Fu-
ture experiments should help us to under-
stand the potential role played by this inter-
esting sequence in the CEA gene family. 
The chromosomal localization of the dif-
ferent members of the CEA gene family was 
independently determined using two differ-
ent techniques. One approach was to analyse 
human/mouse somatic cell hybrids wi th a 
partial CEA cDNA probe [59]. The second 
approach utilized human metaphase chro-
mosome spreads which were hybridized wi th 
probes from the 'repeat' regions of the NCA-
50 gene and a CEA cDNA [77]. I n both 
cases, all genes belonging to the CEA family 
were located on chromosome 19. A major 
gene cluster is found on the long arm o f this 
chromosome, and a second locus is indicated 
at the end of the short arm. Such gene clus-
ters have been found for other gene families; 
e.g., the immunoglobulins [90], the major 
histocompatibility complex [91], or the glo-
bin gene family [92]. In all cases, where 
known, the members of a given gene family 
show similar functions, and the existence of 
gene clusters may help coordinate expression 
of the individual genes. For example, cis-act-
ing enhancer sequences could activate more 
than one gene within such a cluster. 
Expression of the CEA-Gene Family 
The expression of the CEA-gene family 
has been studied in a number of tumours 
and some normal tissues [77, 93]. For these 
studies, various regions from the coding and 
non-coding regions were used to probe 
RNAs in Northern blot hybridization analy-
ses. I t has been possible to identify at least 
six different RNA molecules belonging to 
this family with gene-specific D N A frag-
ments. For CEA, two mRNAs have been 
found which appear to be encoded by one 
gene with two polyadenylation sites [58]. 
The mRNA for NCA-50 could be shown to 
be gene-specific through hybridization under 
stringent conditions, with the NCA-50 3'-
untranslated region. A fourth mRNA species 
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has been found in RNA insolated from 
chronic myeloid leukaemia granulocytes. 
This m R N A hybridizes with probes from the 
coding regions of NCA-50 or CEA, but dif-
fers i n its size and the 3'-untranslated region. 
At least two other mRNA species belonging 
to the CEA family have been reported to be 
expressed in a choriocarcinoma and in fetal 
liver [62, 94]. 
Preliminary studies on the expression of 
these mRNAs in human tumours derived 
from different tissues have already revealed 
some interesting results [77]. Firstly, CEA 
and NCA-50 mRNAs show great variability 
in their absolute as well as their relative 
amounts in a number of different tumours. 
A strong expression of CEA mRNA was 
found in adenocarcinomas of the colon, and 
to a lesser extent, in an adenocarcinoma of 
the pancreas. This correlates well with the 
high CEA-positivity of these tumours [12]. 
These two tumour types also expressed 
NCA-50 mRNA, whereas a squamous carci-
noma of the lung only expressed the NCA-50 
mRNA. I t was recently reported [56, 93] that 
normal colon and colon tumours contain 
similar amounts of CEA mRNAs, although 
pronounced differences in the relative anti-
gen amounts are obvious: approximately 10-
100 X more CEA is found in colon tumours 
than in normal colon. This indicates that a 
post-transcriptional control may be impor-
tant in regulating the expression of CEA in 
colonic tissues. The mRNA species found in 
granulocytes from patients with chronic my-
eloid leukaemia appears to be unique to this 
type of malignancy and may represent a 
member of the CEA family which is specifi-
cally expressed in the myeloid cell lineage. 
Indeed, recent immunological and biochem-
ical evidence suggests that this mRNA may 
code for an NCA-97 in granulocytes [F. 
Grunert, personal commun.], which is pre-
sumed to be identical to NCA-95 [30] (ta-
ble I ) . Such results indicate that other mem-
bers of the CEA family may also be of poten-
tial clinical use as tumour markers. It wi l l be 
of interest to make more extended screen-
ings of human tumours as well as their corre-
sponding normal tissues for the presence of 
mRNAs of members of the CEA gene family 
in order to attempt a correlation between 
their expression and the malignant pheno-
type. 
Expression of C E A and NCA-50 in 
Heterologous Systems 
Prokaryotic Systems 
The subcloning of CEA, NCA-50, as well 
as fragments of these cDNA molecules into 
expression vectors, followed by transfection 
into Escherichia coli, has allowed their ex-
pression in prokaryotes. This system has so 
far been utilized either to isolate CEA family 
cDNA clones, by identification of expressed 
peptides with polyclonal anti-CEA sera [58, 
59], or to map epitopes responsible for 
CEA/NCA MAb-binding [95, 96]. The ex-
pressed proteins have thus been immunolog-
ically confirmed as belonging to the CEA 
family. 
Although some MAbs, which recognize 
epitopes common to different members of 
the CEA family [97], bind to a CEA fragment 
lacking the N-terminal domain [96], the 
available data support the notion that the N -
terminal regions of CEA and NCA-50 con-
tain some of the major antigenic sites. An 
NCA-specific, as well as a CEA/NCA cross-
reacting M A b bind to the last third of the 
N-terminal domain of an NCA-50 deletion 
mutant [95], and a further cross-reacting 
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M A b recognizes the N-terminal region of 
CEA [96]. Finer mapping of these epitopes 
wil l eventually identify the amino-acids re-
sponsible for the specificity of M A b binding. 
A possible explanation for the high antige-
nicity of these N-terminal domains may be 
found in the predicted 'immunoglobulin 
fold' for these regions in CEA and NCA-50 
[73]. The region on NCA-50 which binds the 
NCA-specific M A b [95] is analogous to the 
surface loop in immunoglobulins which con-
nects the two antiparallel beta sheets [73]. 
Furthermore, the N-terminal domains of 
CEA and NCA-50 are not stabilized by a d i -
sulphide bridge. The increased flexibility 
and the surface accessibility may well ac-
count for the high antigenicity of this re-
gion. 
However, the assessment of conforma-
tional epitopes, utilizing the prokaryotic ex-
pression of proteins, is hampered by the fact 
that bacteria exhibit a high reductive poten-
tial, which could possibly induce atypical 
foldings of heterologously expressed pro-
teins. Furthermore, the lack of protein glyco-
sylation plus the production of inclusion 
bodies containing over-produced, crystal-
lized proteins cause additional difficulties in 
obtaining 'native' antigenic proteins. The 
use of eukaryotic expression systems circum-
vents most of these problems. 
Eukaryotic Systems 
Expression of CEA and CEA-like mole-
cules has so far been achieved either by 
transfection of mouse L-cells with total hu-
man D N A [59] or by transfection of a euka-
ryotic expression vector containing the cod-
ing region of CEA into Chinese hamster cells 
[57]. 
Immunofluorescence staining with anti-
CEA sera as well as cell surface labelling fol-
lowed by immunoprecipitation localized 
CEA-like molecules onto the cell membrane. 
The molecule identified on L-cells had a 
lower molecular weight (150,000) than that 
isolated from the hamster cells (180,000). 
The latter has the exact weight of CEA puri-
fied from human tumours and indeed reacts 
with a M A b specific for CEA. Whether the 
smaller molecular weight of the CEA-reac-
tive molecule in L-cells is due to different 
glycosylation, differential processing, or ex-
pression of a cross-reacting antigen remains 
to be clarified. 
The advantages of eukaryotic expression 
systems for analysing the expression of 
members of the CEA gene family are mani-
fold. For example, transfected L-cells pro-
vide an elegant method for raising highly 
specific antibodies against CEA and related 
proteins in syngeneic animals [59]. Secondly, 
analyses of transfectants should yield useful 
information regarding post-transcriptional 
and post-translational processing of individ-
ual gene products, which would be synthe-
sized as a controlled variable in an otherwise 
constant system. Finally, functional studies 
may be carried out. As already mentioned, 
the structural similarity of the CEA family to 
members of the immunoglobulin super-
family could suggest a recognition or recep-
tor function. Using this system, first investi-
gations may be directed toward studying, for 
example, the possible role of CEA and re-
lated proteins in intercellular recognition. 
Evolution of the C E A Gene Family 
Recent investigations in our laboratory 
have revealed the existence of a CEA-like 
gene family as far down the evolutionary 
scale as rodents [results to be published]. 
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Investigations below this animal order have 
not been performed. D N A hybridization 
analyses indicate a strong sequence diver-
gence between rodents and primates, as hu-
man CEA/NCA-50 probes barely hybridize 
wi th restriction endonuclease digests of total 
rodent DNA. Despite this, a number of 
clones have been isolated from a rat genomic 
library which represent four different gene 
loci and which show sequence homology to 
the N-terminal domain of human NCA-50 as 
well as conservation of the exon structure 
[results to be published]. The sequence d i -
vergence with respect to the human CEA 
gene family, as indicated throught the D N A 
hybridization studies, has been confirmed at 
the nucleotide level for each rat gene. That 
genes of the CEA-like family are also ex-
pressed in the rat has been shown through 
hybridization of restriction endonuclease 
fragments containing part of the exon region 
of each clone, with rat poly(A)-RNA. De-
spite the description of molecules with simi-
lar expression patterns and biochemical 
properties to CEA in the rat [98], earlier 
investigations were unable to detect CEA or 
NCA below the higher primates using immu-
nochemical methods [99]. This is under-
standable when we see the great sequence 
divergence below the primates. 
On comparing different members of the 
CEA family in humans, the extremely high 
conservation of sequences for corresponding 
domains is obvious (table I I ) . I t may be of 
interest to note that the N-terminal domain 
as well as the first repeat from CEA show the 
highest conservation with respect to the cor-
responding NCA-50 domains. This could in-
dicate that these domains are under a higher 
selective pressure than the second and third 
CEA repeats, possibly for functional reasons. 
In this manner, other, or modified functions 
could have evolved for the second and third 
CEA repeats. Such a mechanism of domain 
duplication, followed by functional diver-
gence, has been discussed as a general phe-
nomenon enabling proteins to perform new 
or more complex functions [65]. The general 
high level of sequence similarity between 
CEA gene family members is not confined to 
the coding regions alone, as conservation has 
also been found in the 3'- and 5' untrans-
lated regions (compare 57 and 75) as well as 
in intron regions [results to be published]. 
The analyses carried out so far in the rat sys-
tem also indicate a relatively high degree of 
sequence conservation between the different 
CEA-like genes within this species [results to 
be published]. Taking into account the 
strong sequence divergence between the 
CEA families in the two species, this leads us 
to the idea that the families may have arisen 
independently through parallel gene amplifi-
cation of a primordial gene, which was 
present before mammalian radiation took 
place. A model for the evolution of this gene 
family is proposed in figure 4. The existence 
of gene clusters on chromosome 19, as de-
scribed above, suggests the duplication of a 
primordial gene through unequal crossing 
over, giving rise to the various members of 
the CEA gene family. 
The basic building unit can be inferred by 
comparing internal sequence similarities 
within the different domains. The N-ter-
minus and the half-repeats reveal sequence 
similarities, especially in one region (fig. 4, 
shaded area), indicating a common origin 
[66, 75]. I t is of interest to note that the rat 
clones which have been isolated also show a 
higher sequence conservation in this same 
region in comparison with the N-terminus of 
CEA and of NCA-50. This indicates that this 
region may have functional importance. The 
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MAb recognizes the N-terminal region of 
CEA [96]. Finer mapping of these epitopes 
wil l eventually identify the amino-acids re-
sponsible for the specificity of MAb binding. 
A possible explanation for the high antige-
nicity of these N-terminal domains may be 
found in the predicted 'immunoglobulin 
fold' for these regions in CEA and NCA-50 
[73]. The region on NCA-50 which binds the 
NCA-specific M A b [95] is analogous to the 
surface loop in immunoglobulins which con-
nects the two antiparallel beta sheets [73]. 
Furthermore, the N-terminal domains of 
CEA and NCA-50 are not stabilized by a d i -
sulphide bridge. The increased flexibility 
and the surface accessibility may well ac-
count for the high antigenicity of this re-
gion. 
However, the assessment of conforma-
tional epitopes, utilizing the prokaryotic ex-
pression of proteins, is hampered by the fact 
that bacteria exhibit a high reductive poten-
tial, which could possibly induce atypical 
foldings of heterologously expressed pro-
teins. Furthermore, the lack of protein glyco-
sylation plus the production of inclusion 
bodies containing over-produced, crystal-
lized proteins cause additional difficulties in 
obtaining 'native' antigenic proteins. The 
use of eukaryotic expression systems circum-
vents most of these problems. 
Eukaryotic Systems 
Expression of CEA and CEA-like mole-
cules has so far been achieved either by 
transfection of mouse L-cells with total hu-
man D N A [59] or by transfection of a euka-
ryotic expression vector containing the cod-
ing region of CEA into Chinese hamster cells 
[57]. 
Immunofluorescence staining with anti-
CEA sera as well as cell surface labelling fol-
lowed by immunoprecipitation localized 
CEA-like molecules onto the cell membrane. 
The molecule identified on L-cells had a 
lower molecular weight (150,000) than that 
isolated from the hamster cells (180,000). 
The latter has the exact weight of CEA puri-
fied from human tumours and indeed reacts 
with a M A b specific for CEA. Whether the 
smaller molecular weight of the CEA-reac-
tive molecule in L-cells is due to different 
glycosylation, differential processing, or ex-
pression of a cross-reacting antigen remains 
to be clarified. 
The advantages of eukaryotic expression 
systems for analysing the expression of 
members of the CEA gene family are mani-
fold. For example, transfected L-cells pro-
vide an elegant method for raising highly 
specific antibodies against CEA and related 
proteins in syngeneic animals [59]. Secondly, 
analyses of transfectants should yield useful 
information regarding post-transcriptional 
and post-translational processing of individ-
ual gene products, which would be synthe-
sized as a controlled variable in an otherwise 
constant system. Finally, functional studies 
may be carried out. As already mentioned, 
the structural similarity of the CEA family to 
members of the immunoglobulin super-
family could suggest a recognition or recep-
tor function. Using this system, first investi-
gations may be directed toward studying, for 
example, the possible role of CEA and re-
lated proteins in intercellular recognition. 
Evolution of the C E A Gene Family 
Recent investigations in our laboratory 
have revealed the existence of a CEA-like 
gene family as far down the evolutionary 
scale as rodents [results to be published]. 
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Investigations below this animal order have 
not been performed. D N A hybridization 
analyses indicate a strong sequence diver-
gence between rodents and primates, as hu-
man CEA/NCA-50 probes barely hybridize 
with restriction endonuclease digests of total 
rodent D N A . Despite this, a number of 
clones have been isolated from a rat genomic 
library which represent four different gene 
loci and which show sequence homology to 
the N-terminal domain of human NCA-50 as 
well as conservation of the exon structure 
[results to be published]. The sequence d i -
vergence with respect to the human CEA 
gene family, as indicated throught the D N A 
hybridization studies, has been confirmed at 
the nucleotide level for each rat gene. That 
genes of the CEA-like family are also ex-
pressed in the rat has been shown through 
hybridization of restriction endonuclease 
fragments containing part of the exon region 
of each clone, with rat poly(A)-RNA. De-
spite the description of molecules with simi-
lar expression patterns and biochemical 
properties to CEA in the rat [98], earlier 
investigations were unable to detect CEA or 
NCA below the higher primates using immu-
nochemical methods [99]. This is under-
standable when we see the great sequence 
divergence below the primates. 
On comparing different members of the 
CEA family in humans, the extremely high 
conservation of sequences for corresponding 
domains is obvious (table I I ) . I t may be of 
interest to note that the N-terminal domain 
as well as the first repeat from CEA show the 
highest conservation with respect to the cor-
responding NCA-50 domains. This could in-
dicate that these domains are under a higher 
selective pressure than the second and third 
CEA repeats, possibly for functional reasons. 
In this manner, other, or modified functions 
could have evolved for the second and third 
CEA repeats. Such a mechanism of domain 
duplication, followed by functional diver-
gence, has been discussed as a general phe-
nomenon enabling proteins to perform new 
or more complex functions [65]. The general 
high level of sequence similarity between 
CEA gene family members is not confined to 
the coding regions alone, as conservation has 
also been found in the 3'- and 5' untrans-
lated regions (compare 57 and 75) as well as 
in intron regions [results to be published]. 
The analyses carried out so far in the rat sys-
tem also indicate a relatively high degree of 
sequence conservation between the different 
CEA-like genes within this species [results to 
be published]. Taking into account the 
strong sequence divergence between the 
CEA families in the two species, this leads us 
to the idea that the families may have arisen 
independently through parallel gene amplifi-
cation of a primordial gene, which was 
present before mammalian radiation took 
place. A model for the evolution of this gene 
family is proposed in figure 4. The existence 
of gene clusters on chromosome 19, as de-
scribed above, suggests the duplication of a 
primordial gene through unequal crossing 
over, giving rise to the various members of 
the CEA gene family. 
The basic building unit can be inferred by 
comparing internal sequence similarities 
within the different domains. The N-ter-
minus and the half-repeats reveal sequence 
similarities, especially in one region (fig. 4, 
shaded area), indicating a common origin 
[66, 75]. I t is of interest to note that the rat 
clones which have been isolated also show a 
higher sequence conservation in this same 
region in comparison with the N-terminus of 
CEA and of NCA-50. This indicates that this 
region may have functional importance. The 
80 Thompson /Z immermann 
peptide o f the carcinoembryonic antigen synthe-
sized by human tumor cell lines i n the presence o f 
tunicamycin. M o l I m m u n o l 1984;21:743-746. 
14 0rjasaeter A: Demonstrat ion o f carcinoem-
bryonic antigens (CEA), non-specific crossreact-
ing antigens ( N C A ) and an associated alpha pro-
tein in normal human tissues and fluids by i m m u -
nodiffusion techniques. Acta Pathol. M i c r o b i o l 
Scand Section B 1974;82:387-395. 
15 Svenberg T: Carcinoembryonic antigen-like sub-
stances o f human bile. Isolation and partial char-
acterization. In t J Cancer 1976;17:588-596. 
16 K u o T, Rosai J, Ti l lack T W : Immunological stud-
ies o f membrane glycoproteins isolated f rom hu-
man breast carcinomas. In t J Cancer 1973; 12: 
532-542. 
17 Ima i K , Mor iya Y , Fujita H , et al: Immunological 
characterization and molecular profile o f CEA 
detected by monoclonal antibodies. J I m m u n o l 
1984;132:2992-2997. 
18 Grunert F, AbuHarfe i l N , Schwarz K , et al: T w o 
CEA and three N C A species, although dis t in-
guishable by monoclonal antibodies, have nearly 
identical peptide pattern. In t J Cancer 1985;36: 
357-362. 
19 Darcy D A , Turbervi l le C, James R: Immunolog i -
cal study o f carcinoembryonic antigen (CEA) and 
a related glycoprotein. Br J Cancer 1973;28:147— 
160. 
20 Turbervi l le C, Darcy D A , Laurence DJR, et al: 
Studies on carcinoembryonic antigen and a re-
lated glycoprotein CCEA-2: preparation and 
chemical characterization. Immunochemistry 
1973;10:841-843. 
21 Newman ES, Petras SE, Georgiadis A, et al: Inter-
relationship o f carcinoembryonic antigen and co-
lon carcinoma antigen-III . Cancer Res 1974;34: 
2125-2130. 
22 H ä k k i n e n I : Immunological relationship o f CEA 
and the fetal sulfoglycoprotein antigen. Immuno-
chemistry 1972;9:1115-1119. 
23 Vuento M , Engvall E, Seppälä M , et al: Isolation 
from human gastric juice o f an antigen closely 
related to the carcinoembryonic antigen. Int J 
Cancer 1976;18:156-160. 
24 Primus FJ, Freeman JW, Goldenberg D M : I m m u -
nological heterogeneity o f carcinoembryonic ant i-
gen: purif ication from meconium o f an antigen 
related to carcinoembryonic antigen. Cancer Res 
1983;43:679-685. 
25 Siepen D , Paxton RJ, Neumaier M , et al: Carci-
noembryonic antigen (CEA) and two crossreactive 
antigens o f 165 k D and 105 k D isolated from 
meconium exhibit identical amino terminal se-
quences. Biochem Biophys Res C o m m u n 1987; 
147:212-218. 
26 Liao S-K, Kwong PC, Clarke BJ, et al: Mono-
clonal antibody recognizing melanoma-carcinoma 
cross-reacting oncofetal antigen epitopically asso-
ciated w i t h carcinoembryonic antigen. J N C I 
1985;74:1047-1058. 
27 Bur t in P, Chavannel G , Hi r sch-Mar ie H : Charac-
terization o f a second normal antigen that cross-
reacts w i t h CEA. J I m m u n o l 1973; 111:1926-
1928. 
28 Audette M , Buchegger F, Schreyer M , et al: Mono-
clonal antibody against carcinoembryonic antigen 
(CEA) identifies two new forms o f crossreacting 
antigens o f molecular weight 90,000 and 160,000 
in normal granulocytes. M o l I m m u n o l 1987;24: 
1177-1186. 
29 Engvall E, Shively JE, W r a n n M : Isolation and 
characterization o f the normal crossreacting anti-
gen: homology o f its N H 2 - t e r m i n a l amino acid 
sequence w i t h that o f carcinoembryonic antigen. 
Proc Na t l Acad Sei U S A 1978;75:1670-1674. 
30 Buchegger F, Schreyer M , Carrel S, et al: Mono-
clonal antibodies identify a CEA crossreacting an-
tigen o f 95 k D (NCA-95) dist inct in antigenicity 
and tissue d is t r ibut ion f rom the previously de-
scribed N C A o f 55 k D . In t J Cancer 1984;33:643-
649. 
31 von Kleist S, Chavanel G , B u r t i n P: Identif icat ion 
o f an antigen from normal human tissue that 
crossreacts w i t h the carcinoembryonic antigen. 
Proc Nat l Acad. Sei USA 1972;69:2492-2494. 
32 K u r o k i M , Shinoda T , Takayasu T , et al: I m m u -
nological characterization and structural studies 
o f normal fecal antigen-1 related to carcinoem-
bryonic antigen. M o l I m m u n o l 1982; 19:399-
406. 
33 Matsuoka Y , K u r o k i M , Koga Y , et al: Immuno-
chemical differences among carcinoembryonic 
antigen in tumor tissues and related antigens in 
meconuim and adult feces. Cancer Res 1982;42: 
2012-2018. 
34 K u r o k i M , Koga Y , Matsuoka Y : Purif ication and 
characterization o f CEA-related antigens in nor-
mal adult feces. Cancer Res 1981;41:713-720. 
35 Mach JP, Pusztaszeri G: Demonst ra t ion o f a par-
CEA Gene Fami ly 81 
tial ident i ty between CEA and normal glycopro-
tein. Immunochemis t ry 1972;9:1031-1034. 
36 Kessler M J , Shively JE, Pri tchard D G , et al: Isola-
t ion , immunolog ica l characterization, and struc-
tural studies o f a t u m o r antigen related to carci-
noembryonic antigen. Cancer Res 1978;38:1041— 
1048. 
37 Blaszczyk M , Pak K Y , Her lyn M , et al: Character-
izat ion o f gastrointestinal tumor-associated carci-
noembryonic antigen-related antigens defined by 
monoclonal antibodies. Cancer Res 1984;44:245-
253. 
38 Neumaier M , Fenger U , Wagener Ch: Monoclonal 
antibodies for carcinoembryonic antigen (CEA) as 
a model system: Ident i f ica t ion o f two novel CEA-
related antigens i n meconium and colorectal car-
cinoma tissue by western blots and differential 
immunoaf f in i ty chromatography. J I m m u n o l 
1985;135:3604-3609. 
39 Her lyn M , Blaszczyk M , Sears H F , et al: Detection 
o f a carcinoembryonic antigen and related ant i-
gens i n sera o f patients wi th gastrointestinal tu-
mors using monoclonal antibodies in double de-
terminant radioimmunoassays. Hybr idoma 1983; 
2:329-339. 
40 Laferte S, Kran tz M J : Purification and character-
izat ion o f a 50,000 m o l . wt. glycoprotein antigen, 
and localization o f determinants involved in 
cross-reactivity w i t h carcinoembryonic antigen. 
M o l I m m u n o l 1983;20:421-431. 
41 H a m m a r s t r ö m S, Svenberg T , Hedin A, et al: 
Antigens related to carcinoembryonic antigen. 
Scand J I m m u n o l 1978;7 (suppl 6):33-46. 
42 Banjo C, Shuster J, G o l d P: lntermolecular heter-
ogeneity o f the carcinoembryonic antigen. Cancer 
Res 1974;34:2114-2121. 
43 Grunert F, Hernando JJ, Schwarz K , et al: D o 
CEA molecules exhibi t organ specific differences? 
In t Soc Oncodev Bio l Med: X V t h A n n u Meet, 
Quebec, 1987, abstr. 131. 
44 Paxton RJ, Hefta S, Shively JE, et al: Protein 
sequence analysis o f the carcinoembryonic anti-
gen gene family . In t Soc Oncodev Biol Med: X V t h 
Annu Meet, Quebec, 1987, abstr. 139. 
45 Grunert F, AbuHar fe i l N , Luckenbach G A , et al: 
Isolation and characterization o f two proteins co-
puri fying w i t h carcinoembryonic antigen. T u -
mour Biol 1984;5:221-232. 
46 Bur t in P, Quan PC, Sabine M C : Nonspecific cross 
reacting antigen as a marker for human poly-
morphs, macrophages and monocytes. Nature 
1975;255:714-716. 
47 Bordes M , Knobel S, M a r t i n F: Carcinoembryonic 
antigen (CEA) and related antigens in blood cells 
and hematopoetic cells. Eur J Cancer 1975; 11: 
783-786. 
48 Heumann D , Candarjis P, Carrel S, et al: Ident i f i -
cation o f the normal glycoprotein (NGP) cross-
reacting w i th CEA as a differentiation antigen o f 
myeloid cells and macrophages; i n Lehmann F G 
(ed): Carcino-embryonic Proteins. Amsterdam, 
Elsevier/North Hol land Biomedical Press, 1979, 
vol 11, pp 3-14. 
49 Wahren B; Gahrton G, H a m m a r s t r ö m S: Nonspe-
cific crossreacting antigen i n normal and leukemic 
myeloid cells and serum o f leukemic patients. 
Cancer Res 1980;40:2039-2044. 
50 D i l l m a n RO, Beauregard JC, Sobol RE, et al: Lack 
o f radioimmunodetect ion and complications as-
sociated w i t h monoclonal anticarcinoembryonic 
antigen antibody cross-reactivity w i t h an antigen 
on circulating cells. Cancer Res 1984;44:2213-
2218. 
51 H a m m a r s t r ö m S, Engvall E, Johansson B G , et al: 
Nature o f the tumor-associated determinant(s) o f 
carcinoembryonic antigen. Proc Nat l Acad Sei 
USA 1975;72:1528-1532. 
52 Rogers G T : Carcinoembryonic antigens and re-
lated glycoproteins: molecular aspects and speci-
fici ty. Biochim Biophys Acta 1983;695:227-249. 
53 Z immermann W , Friedrich R, Grunert F, et al: 
Characterization o f messenger R N A specific for 
carcinoembryonic antigen. A n n N Y Acad Sei 
1983;417:21-30. 
54 Z immermann W , Thompson J, Grunert F, et al: 
Identif icat ion o f messenger R N A coding for carci-
noembryonic antigen. Contr ib Oncol 1984; 19:64-
74. 
55 Paxton RJ, Mooser G, Pande H , et al: Sequence 
analysis o f carcinoembryonic antigen: Identifica-
t ion o f glycosylation sites and homology wi th the 
immunoglobul in supergene family. Proc Nat l 
Acad Sei USA 1987;84:920-924. 
56 Z immermann W, Ort l ieb B, Friedrich R, et al: 
Isolation and characterization o f c D N A clones 
encoding the human carcinoembryonic antigen 
reveal a highly conserved repeating structure. 
Proc Nat l Acad Sei USA 1987;84:2960-2964. 
57 Beauchemin N , Benchimol S, Cournoyer D , et al: 
Isolation and characterization o f full length func-
82 Thompson/Zimmermann 
t ional c D N A clones for human carcinoembryonic 
antigen (CEA). M o l Cell Bio l 1987;7:3221-3230. 
58 Oikawa S, Nakazato H , Kosaki G: Primary struc-
ture o f human carcinoembryonic antigen (CEA) 
deduced from c D N A sequence. Biochem Biophys 
R e s C o m m u n 1987;142:511-518. 
59 Kamarck M E , Elt ing JJ, Har t JT, et al: Carci-
noembryonic antigen family: expression i n a 
mouse L-cell transfectant and characterization o f 
a partial c D N A in bacteriophage Xgt 11. Proc Nat l 
Acad Sei USA 1987;84:5350-5354. 
60 Thompson JA, Pande H , Paxton RJ, et al: Molec-
ular cloning o f a gene belonging to the carcinoem-
bryonic antigen gene family and discussion o f a 
domain model. Proc Nat l Acad Sei USA 1987;84: 
2965-2969. 
61 Oikawa S, Kosaki G, Nakazato H : Molecular clon-
ing o f a gene for a member o f carcinoembryonic 
antigen (CEA) gene family; signal peptide and N -
terminal domain sequences o f nonspecific cross-
reacting antigen (NCA) . Biochem Biophys Res 
C o m m u n 1987;146:464-469. 
62 Barnett T , Goebel S, Elt ing J: Cloning and charac-
terization o f c D N A s for CEA and related family 
members. Int Soc Oncodev Bio l Med: X V t h Annu 
Meet, Quebec, 1987, abstr. 150. 
63 Terry W D , Henkart PA, Coligan JE, et al: Struc-
tural study o f the major glycoprotein in prepara-
tions w i th CEA activi ty. J Exp M e d 1972; 136: 
200-204. 
64 Paxton RJ, Simmer R L , Shively JE: Protein struc-
ture and molecular cloning o f carcinoembryonic 
antigen and a related tumor associated antigen 
( T E X ) (abstract). Tumour Bio l . 1985;6:327. 
65 L i W - L : Evolut ion o f duplicate genes and pseudo-
genes; in Nei M , Koehn R K (eds): Evolut ion o f 
Genes and Proteins. Sunderland, Sinauer, 1983, 
pp 14-37. 
66 Oikawa S, Imajo S, Noguchi T, et al: The carci-
noembryonic antigen (CEA) contains mul t ip le i m -
munoglobulin-l ike domains. Biochem Biophys 
Res Commun 1987;144:634-642. 
67 Yarden Y , Escobedo JA, Kuang W-J, et al: Struc-
ture o f the receptor for platelet-derived growth 
factor helps define a family o f closely related 
growth factor receptors. Nature 1986;323:226-
232. 
68 Dust in M L , Selvarj P, Mattal iano RJ, et al: A n -
choring mechanisms for LFA-3 cell adhesion gly-
coprotein at membrane surface. Nature 1987;329: 
846-848. 
69 Low M G : Biochemistry o f the glycosyl-phosphati-
dylinosi tol membrane protein anchors. Biochem J 
1987;244:1-13. 
70 Chandrasekaran EV, Davi la M , N i x o n D W , et al: 
Isolation and structures o f the oligosaccharide 
units o f carcinoembryonic antigen. J Biol Chem 
1983;258:7213-7222. 
71 Plow EF, Edgington TS: Speciation o f carcinoem-
bryonic antigen and its immunodiagnostic i m p l i -
cations: i n Herberman RB, M c l n t i r e K R (eds): 
Immunodiagnosis o f Cancer. New York , Dekker, 
1979, vol 9 (part I ) , pp 181-239. 
72 AbuHarfe i l N , Grunert F, von Kleist S: Non-spe-
cific crossreacting antigen ( N C A ) does not contain 
methionine. Tumour Biol 1984;5:339-350. 
73 Wil l iams A F : A year in the life o f the immuno-
globulin superfamily. I m m u n o l Today 1987;8: 
298-303. 
74 Jelinek W R , Schmid CW: Repetitive sequences in 
eukaryotic D N A and their expression. A n n u Rev 
Biochem 1982;51:813-844. 
75 Neumaier M , Z immermann W , Shively L , et al: 
Characterization o f a c D N A clone for the nonspe-
cific crossreacting antigen ( N C A ) and a compari-
son o f N C A and carcinoembryonic antigen (CEA). 
J Biol Chem, in press. 
76 Grunert F, Schwarz K , Paxton R, et al: Compari-
son o f amino acid sequences f rom deglycosylated 
NCA-50 and DNA-deduced sequences. Int Soc 
Oncodev Biol Med: X V t h A n n u Meet, Quebec, 
1987, abstr. 132. 
77 Z immermann W, Weber B, Ort l ieb B, et al: Chro-
mosomal localization o f the carcinoembryonic an-
tigen gene family and differential expression in 
various tumors. Cancer Res, in press 
78 Chan SJ, San Secundo B, M c C o r m i c k M B , et al: 
Nucleotide and predicted amino acid sequences o f 
cloned human and mouse preprocathepsin B 
cDNAs . Proc Nat l Acad Sei USA 1986;83:7721-
7725. 
79 Miya ta T , Yasumaga T, Nishida T : Nucleotide 
sequence divergence and functional constraints in 
m R N A evolution. Proc Nat l Acad Sei USA 1980; 
77:7328-7332. 
80 Lisowska E, Krop-Watorek A, Sedlaczek P: The 
dimeric structure o f carcinoembryonic antigen 
(CEA). Biochem Biophys Res C o m m u n 1983;115: 
206-211 . 
81 Lisowska E, Krop-Watorek A , Sedlaczek P: Inter-
molecular interactions in CEA and N C A . Int Soc 
CEA Gene Family 83 
Oncodev Biol Med: X V t h A n n u Meet, Quebec, 
1987, abstr. 146. 
82 Thompson J, Rudert F, Mauch E - M , et al: Intra-
and interspecies evolut ion o f the CEA gene fami-
ly. In t Soc Oncodev Biol Med: X V t h A n n u Meet, 
Quebec, 1987, abstr. 133. 
83 Hamada H , Petrino M G , Kagunaga T , et al: Char-
acterization o f genomic poly(dT-dG) * poly(dC-
dA) sequences: Structure, organization, and con-
formation. M o l Cell B io l 1984;4:2610-2621. 
84 Vorl ickova M , K y p r J, Stokrova S, et al: A Z-like 
form o f poly(dA-dC)-poly(dG-dT) i n solution? 
Nucleic Acids Res 1982;10:1071-1080. 
85 Quax W, Egberts W V , Hendriks W , et al: The 
structure o f the v iment in gene. Cell 1983;35:215-
223. 
86 Hamada H , Seidman M , Howard B H , et al: En-
hanced gene expression by the p o l y ( d T -
dG) -po ly (dC-dA) sequence. M o l Cell Bio l 1984; 
4:2622-2630. 
87 Hani ford D B , Pulleyblank D E : The i n v ivo occur-
rence o f Z - D N A . J B iomol Struct Dynam 1983;1: 
593-609. 
88 Proudfoot NJ , Maniat is T: The structure o f a 
human a-globin pseudogene and its relationship 
to a-globin gene duplicat ion. Cell 1980;21:537-
544. 
89 Slightom JL, Blechl A E , Smithies O: H u m a n fetal 
G y - and A y-globin genes: Complete nucleotide se-
quences suggest that D N A can be exchanged be-
tween these duplicated genes. Cell 1980;21:627-
638. 
90 Tonegawa S: Somatic generation o f antibody d i -
versity. Nature 1983;302:575-581. 
91 Steinmetz M , Hood L: Genes o f the major histo-
compat ibi l i ty complex in mouse and man. Science 
1983;222:727-733. 
92 Maniat is T , Fritsch EF, Lauer J, et al: The molec-
ular genetics o f human hemoglobins. A n n u Rev 
Genet 1980;14:145-178. 
93 Cournoyer D , Boucher D , Beauchemin N , et al: 
Use o f a c D N A probe for carcinoembryonic ant i-
gen for the analysis o f CEA gene expression i n 
malignant and normal human tissues. In t Soc On-
codev Biol Med: X V t h A n n u Meet, Quebec, 1987, 
abstr. 148. 
94 Khan W , Osterman A, H a m m a r s t r ö m S: Molec-
ular cloning o f carcinoembryonic antigen and 
related macromolecules. In t Soc Oncodev Bio l 
Med: X V t h A n n u Meet, Quebec, 1987. 
abstr. 144. 
95 Schwarz K , Brückel N , Kolbinger F, et al: Ex-
pression o f a member o f the carcinoembryonic 
antigen glycoprotein family in Escherichia coli. 
In t Soc Oncodev Biol Med: X V t h A n n u Meet, 
Quebec, 1987, abstr. 137. 
96 Matsuoka Y , K u r o k i M , Oikawa S, et al: A n t i -
genic reactivity o f recombinant CEA peptides. 
In t Soc Oncodev Bio l Med: X V t h A n n u Meet, 
Quebec, 1987, abstr. 143. 
97 K u r o k i M , K u r o k i M , Koka Y , et al: Monoclonal 
antibodies to carcinoembryonic antigen: A sys-
tematic analysis o f antibody specificities by us-
ing related normal antigens and evidence for 
allotypic determinants on carcinoembryonic an-
tigen. J I m m u n o l 1984;133:2090-2097. 
98 Abeyounis CJ, M i l g r o m F: A thermostable ant i -
gen characteristic for carcinogen-induced rat i n -
testinal tumors. J I m m u n o l 1976;116:30-34. 
99 Wahren B, Gadler F, Gahrten G, et al: N C A : A 
differentiation antigen o f myelopoietic cells i n 
humans and homino id monkeys. A n n N Y Acad 
Sei 1983;417:344-358. 
100 Hunkapi l ler T , H o o d L: The growing immuno-
globulin gene superfamily. Nature 1986;323:15-
16. 
101 Tawaragi Y , Oikawa S, Matsuoka Y , et al: Pr i -
mary structure o f nonspecific crossreacting ant i-
gen ( N C A ) , a member o f carcinoembryonic anti-
gen (CEA) gene family, deduced from c D N A 
sequence. Biochem Biophys Res Commun 1988; 
150:89-96. 
Accepted: November 19, 1987 
John Thompson 
Inst i tut für Immunbiologie der 
Un ive r s i t ä t Freiburg 
Stefan-Meier-Strasse 8 
D - 7 8 0 0 Freiburg (FRG) 
